BSEM insider transaction filings
BioStem Technologies, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-17. Screen BSEM transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 13 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
Recent Form 4 filings — BioStem Technologies, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | FORTUNATO MICHAEL A — Chief Accounting Officer | Option exercise (M): 4,234 @ $0 · Option exercise (M): 4,234 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | WARRINGTON KENNETH HOWARD JR — Director | Option exercise (M): 1,694 @ $0 · Option exercise (M): 1,694 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | Matuszewski Jason — Chief Executive Officer, Director, 10% owner | Option exercise (M): 8,469 @ $0 · Option exercise (M): 16,650 @ $0 · Option exercise (M): 8,469 (derivative) @ $0 · Option exercise (M): 16,650 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | SMITH-VAN VURST ANDREW — Chief Operating Officer, Director, 10% owner | Option exercise (M): 7,622 @ $0 · Option exercise (M): 9,574 @ $0 · Option exercise (M): 7,622 (derivative) @ $0 · Option exercise (M): 9,574 (derivative) @ $0 | EDGAR |
| 2026-09-17 | 4 | POE BRANDON — Chief Financial Officer | Option exercise (M): 1,694 @ $0 · Option exercise (M): 1,694 (derivative) @ $0 | EDGAR |
| 2026-09-11 | 4 | HASSETT BARRY — Chief Commercial Officer | Option exercise (M): 500 @ $0 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | SONENREICH STEVEN D — Director | Option exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | WARRINGTON KENNETH HOWARD JR — Director | Option exercise (M): 5,094 @ $0 · Option exercise (M): 5,094 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | Glickman Mark A — Director | Option exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | LESSER HANNAWAY RAYNA — Director | Option exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0 | EDGAR |
| 2026-08-28 | 4 | UNGRODT JODI — Director | Option exercise (M): 5,647 @ $0 · Option exercise (M): 5,647 (derivative) @ $0 | EDGAR |
| 2026-08-20 | 4 | FORTUNATO MICHAEL A — Chief Accounting Officer | Option exercise (M): 970 @ $0 · Option exercise (M): 970 (derivative) @ $0 | EDGAR |
| 2026-08-20 | 4 | POE BRANDON — Chief Financial Officer | Option exercise (M): 10,634 @ $0 · Option exercise (M): 10,634 (derivative) @ $0 | EDGAR |
Recent 8-K events — BioStem Technologies, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BSEM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →